Click for best price
AntiTumor Drugs Market Size, Share 2023
| Market size in 2022 |
US$ 97070 million
|
Forecast Market size by 2029 |
US$ 127900 million
|
| Growth Rate |
CAGR of 4.0% |
Number of Pages |
77 Pages |
Anti-tumor drugs are for the treatment of cancer diseases. In recent years, the development of molecular oncology and molecular pharmacology has gradually clarified the nature of the tumor. The invention and application of advanced technologies such as large-scale rapid screening, combinatorial chemistry and genetic engineering have accelerated the process of drug development. The research and development of anti-tumor drugs have been into a new era.
This report aims to provide a comprehensive presentation of the global market for Anti-Tumor Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Tumor Drugs. This report contains market size and forecasts of Anti-Tumor Drugs in global, including the following market information:
Global Anti-Tumor Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Anti-Tumor Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Anti-Tumor Drugs companies in 2022 (%)
The global Anti-Tumor Drugs market was valued at US$ 97070 million in 2022 and is projected to reach US$ 127900 million by 2029, at a CAGR of 4.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In China, Anti-tumor Drug key players include AstraZeneca, Merck & Co., Roche, Celgene, Johnson & Johnson, etc.
United States is the largest market, followed by Japan, and Europe.
We surveyed the Anti-Tumor Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-Tumor Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-Tumor Drugs Market Segment Percentages, by Type, 2022 (%)
Surgical
Chemotherapy
Radiation
Targeted
Immunotherapy
Global Anti-Tumor Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-Tumor Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital Use
Clinic Use
Household
Other
Global Anti-Tumor Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-Tumor Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-Tumor Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Anti-Tumor Drugs revenues share in global market, 2022 (%)
Key companies Anti-Tumor Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Anti-Tumor Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Novartis
Celgene
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anti-Tumor Drugs, market overview.
Chapter 2: Global Anti-Tumor Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Anti-Tumor Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-Tumor Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Anti-Tumor Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Anti-Tumor Drugs Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 97070 million
|
| Forecast Market size by 2029 |
US$ 127900 million
|
| Growth Rate |
CAGR of 4.0% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
77 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Anti-Tumor Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-Tumor Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-Tumor Drugs Overall Market Size
2.1 Global Anti-Tumor Drugs Market Size: 2022 VS 2029
2.2 Global Anti-Tumor Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Anti-Tumor Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Anti-Tumor Drugs Players in Global Market
3.2 Top Global Anti-Tumor Drugs Companies Ranked by Revenue
3.3 Global Anti-Tumor Drugs Revenue by Companies
3.4 Global Anti-Tumor Drugs Sales by Companies
3.5 Global Anti-Tumor Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Anti-Tumor Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Anti-Tumor Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti-Tumor Drugs Players in Global Market
3.8.1 List of Global Tier 1 Anti-Tumor Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Anti-Tumor Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti-Tumor Drugs Market Size Markets, 2022 & 2029
4.1.2 Surgical
4.1.3 Chemotherapy
4.1.4 Radiation
4.1.5 Targeted
4.1.6 Immunotherapy
4.2 By Type - Global Anti-Tumor Drugs Revenue & Forecasts
4.2.1 By Type - Global Anti-Tumor Drugs Revenue, 2018-2023
4.2.2 By Type - Global Anti-Tumor Drugs Revenue, 2024-2029
4.2.3 By Type - Global Anti-Tumor Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Anti-Tumor Drugs Sales & Forecasts
4.3.1 By Type - Global Anti-Tumor Drugs Sales, 2018-2023
4.3.2 By Type - Global Anti-Tumor Drugs Sales, 2024-2029
4.3.3 By Type - Global Anti-Tumor Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Anti-Tumor Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anti-Tumor Drugs Market Size, 2022 & 2029
5.1.2 Hospital Use
5.1.3 Clinic Use
5.1.4 Household
5.1.5 Other
5.2 By Application - Global Anti-Tumor Drugs Revenue & Forecasts
5.2.1 By Application - Global Anti-Tumor Drugs Revenue, 2018-2023
5.2.2 By Application - Global Anti-Tumor Drugs Revenue, 2024-2029
5.2.3 By Application - Global Anti-Tumor Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Anti-Tumor Drugs Sales & Forecasts
5.3.1 By Application - Global Anti-Tumor Drugs Sales, 2018-2023
5.3.2 By Application - Global Anti-Tumor Drugs Sales, 2024-2029
5.3.3 By Application - Global Anti-Tumor Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Anti-Tumor Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Anti-Tumor Drugs Market Size, 2022 & 2029
6.2 By Region - Global Anti-Tumor Drugs Revenue & Forecasts
6.2.1 By Region - Global Anti-Tumor Drugs Revenue, 2018-2023
6.2.2 By Region - Global Anti-Tumor Drugs Revenue, 2024-2029
6.2.3 By Region - Global Anti-Tumor Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Anti-Tumor Drugs Sales & Forecasts
6.3.1 By Region - Global Anti-Tumor Drugs Sales, 2018-2023
6.3.2 By Region - Global Anti-Tumor Drugs Sales, 2024-2029
6.3.3 By Region - Global Anti-Tumor Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Anti-Tumor Drugs Revenue, 2018-2029
6.4.2 By Country - North America Anti-Tumor Drugs Sales, 2018-2029
6.4.3 US Anti-Tumor Drugs Market Size, 2018-2029
6.4.4 Canada Anti-Tumor Drugs Market Size, 2018-2029
6.4.5 Mexico Anti-Tumor Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Anti-Tumor Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Anti-Tumor Drugs Sales, 2018-2029
6.5.3 Germany Anti-Tumor Drugs Market Size, 2018-2029
6.5.4 France Anti-Tumor Drugs Market Size, 2018-2029
6.5.5 U.K. Anti-Tumor Drugs Market Size, 2018-2029
6.5.6 Italy Anti-Tumor Drugs Market Size, 2018-2029
6.5.7 Russia Anti-Tumor Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Anti-Tumor Drugs Market Size, 2018-2029
6.5.9 Benelux Anti-Tumor Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Anti-Tumor Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Anti-Tumor Drugs Sales, 2018-2029
6.6.3 China Anti-Tumor Drugs Market Size, 2018-2029
6.6.4 Japan Anti-Tumor Drugs Market Size, 2018-2029
6.6.5 South Korea Anti-Tumor Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Anti-Tumor Drugs Market Size, 2018-2029
6.6.7 India Anti-Tumor Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Anti-Tumor Drugs Revenue, 2018-2029
6.7.2 By Country - South America Anti-Tumor Drugs Sales, 2018-2029
6.7.3 Brazil Anti-Tumor Drugs Market Size, 2018-2029
6.7.4 Argentina Anti-Tumor Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Anti-Tumor Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Anti-Tumor Drugs Sales, 2018-2029
6.8.3 Turkey Anti-Tumor Drugs Market Size, 2018-2029
6.8.4 Israel Anti-Tumor Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Anti-Tumor Drugs Market Size, 2018-2029
6.8.6 UAE Anti-Tumor Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Anti-Tumor Drugs Major Product Offerings
7.1.4 Roche Anti-Tumor Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Anti-Tumor Drugs Major Product Offerings
7.2.4 Novartis Anti-Tumor Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 Celgene
7.3.1 Celgene Company Summary
7.3.2 Celgene Business Overview
7.3.3 Celgene Anti-Tumor Drugs Major Product Offerings
7.3.4 Celgene Anti-Tumor Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Celgene Key News & Latest Developments
8 Global Anti-Tumor Drugs Production Capacity, Analysis
8.1 Global Anti-Tumor Drugs Production Capacity, 2018-2029
8.2 Anti-Tumor Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-Tumor Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anti-Tumor Drugs Supply Chain Analysis
10.1 Anti-Tumor Drugs Industry Value Chain
10.2 Anti-Tumor Drugs Upstream Market
10.3 Anti-Tumor Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anti-Tumor Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Anti-Tumor Drugs in Global Market
Table 2. Top Anti-Tumor Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Anti-Tumor Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Anti-Tumor Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Anti-Tumor Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Anti-Tumor Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Anti-Tumor Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Anti-Tumor Drugs Product Type
Table 9. List of Global Tier 1 Anti-Tumor Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-Tumor Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Anti-Tumor Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Anti-Tumor Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Anti-Tumor Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Anti-Tumor Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Anti-Tumor Drugs Sales (K Units), 2024-2029
Table 16. By Application ? Global Anti-Tumor Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Anti-Tumor Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Anti-Tumor Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Anti-Tumor Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Anti-Tumor Drugs Sales (K Units), 2024-2029
Table 21. By Region ? Global Anti-Tumor Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Anti-Tumor Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Anti-Tumor Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Anti-Tumor Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Anti-Tumor Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Anti-Tumor Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Anti-Tumor Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Anti-Tumor Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Anti-Tumor Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Anti-Tumor Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Anti-Tumor Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Anti-Tumor Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Anti-Tumor Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Anti-Tumor Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Anti-Tumor Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Anti-Tumor Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Anti-Tumor Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Anti-Tumor Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Anti-Tumor Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Anti-Tumor Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Anti-Tumor Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Anti-Tumor Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Anti-Tumor Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Anti-Tumor Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Anti-Tumor Drugs Sales, (K Units), 2024-2029
Table 46. Roche Company Summary
Table 47. Roche Anti-Tumor Drugs Product Offerings
Table 48. Roche Anti-Tumor Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Roche Key News & Latest Developments
Table 50. Novartis Company Summary
Table 51. Novartis Anti-Tumor Drugs Product Offerings
Table 52. Novartis Anti-Tumor Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Novartis Key News & Latest Developments
Table 54. Celgene Company Summary
Table 55. Celgene Anti-Tumor Drugs Product Offerings
Table 56. Celgene Anti-Tumor Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Celgene Key News & Latest Developments
Table 58. Anti-Tumor Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 59. Global Anti-Tumor Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 60. Global Anti-Tumor Drugs Production by Region, 2018-2023 (K Units)
Table 61. Global Anti-Tumor Drugs Production by Region, 2024-2029 (K Units)
Table 62. Anti-Tumor Drugs Market Opportunities & Trends in Global Market
Table 63. Anti-Tumor Drugs Market Drivers in Global Market
Table 64. Anti-Tumor Drugs Market Restraints in Global Market
Table 65. Anti-Tumor Drugs Raw Materials
Table 66. Anti-Tumor Drugs Raw Materials Suppliers in Global Market
Table 67. Typical Anti-Tumor Drugs Downstream
Table 68. Anti-Tumor Drugs Downstream Clients in Global Market
Table 69. Anti-Tumor Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Anti-Tumor Drugs Segment by Type in 2022
Figure 2. Anti-Tumor Drugs Segment by Application in 2022
Figure 3. Global Anti-Tumor Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Anti-Tumor Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Anti-Tumor Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Anti-Tumor Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Anti-Tumor Drugs Revenue in 2022
Figure 9. By Type - Global Anti-Tumor Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Anti-Tumor Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Anti-Tumor Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Anti-Tumor Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Anti-Tumor Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Anti-Tumor Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Anti-Tumor Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Anti-Tumor Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Anti-Tumor Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Anti-Tumor Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Anti-Tumor Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Anti-Tumor Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Anti-Tumor Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Anti-Tumor Drugs Sales Market Share, 2018-2029
Figure 23. US Anti-Tumor Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Anti-Tumor Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Anti-Tumor Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Anti-Tumor Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Anti-Tumor Drugs Sales Market Share, 2018-2029
Figure 28. Germany Anti-Tumor Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Anti-Tumor Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Anti-Tumor Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Anti-Tumor Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Anti-Tumor Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Anti-Tumor Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Anti-Tumor Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Anti-Tumor Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Anti-Tumor Drugs Sales Market Share, 2018-2029
Figure 37. China Anti-Tumor Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Anti-Tumor Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Anti-Tumor Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Anti-Tumor Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Anti-Tumor Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Anti-Tumor Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Anti-Tumor Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Anti-Tumor Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Anti-Tumor Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Anti-Tumor Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Anti-Tumor Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Anti-Tumor Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Anti-Tumor Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Anti-Tumor Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Anti-Tumor Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Anti-Tumor Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Anti-Tumor Drugs by Region, 2022 VS 2029
Figure 54. Anti-Tumor Drugs Industry Value Chain
Figure 55. Marketing Channels
